tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NRBO

NeuroBo Pharmaceuticals Reveals Promising Therapeutic Developments
Company AnnouncementsNeuroBo Pharmaceuticals Reveals Promising Therapeutic Developments
5M ago
8K
NRBO
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
PremiumCompany Announcements
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
6M ago
8K
NRBO
NeuroBo Pharmaceuticals announces relignment, change name
PremiumThe Fly
NeuroBo Pharmaceuticals announces relignment, change name
6M ago
NRBO
NeuroBo Pharmaceuticals Completes Phase 2a Trial for MASH Drug
PremiumCompany Announcements
NeuroBo Pharmaceuticals Completes Phase 2a Trial for MASH Drug
6M ago
8K
NRBO
NeuroBo Pharmaceuticals completes last patient visit in Phase 2a DA-1241 trial
PremiumThe Fly
NeuroBo Pharmaceuticals completes last patient visit in Phase 2a DA-1241 trial
6M ago
NRBO
NeuroBo Pharmaceuticals Unveils Updated Corporate Presentation
PremiumCompany AnnouncementsNeuroBo Pharmaceuticals Unveils Updated Corporate Presentation
7M ago
8K
NRBO
NeuroBo’s DA-1726 Shows Promise in Obesity Trial Phase 1
Premium
Company Announcements
NeuroBo’s DA-1726 Shows Promise in Obesity Trial Phase 1
7M ago
8K
NRBO
NeuroBo Pharmaceuticals announces data from SAD Part 1 of trial of DA-1726
Premium
The Fly
NeuroBo Pharmaceuticals announces data from SAD Part 1 of trial of DA-1726
7M ago
NRBO
NeuroBo Pharmaceuticals reports Q2 EPS ($1.85), consensus ($1.12)
PremiumThe Fly
NeuroBo Pharmaceuticals reports Q2 EPS ($1.85), consensus ($1.12)
9M ago
NRBO
NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial
PremiumCompany Announcements
NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial
9M ago
8K
NRBO
NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726
PremiumThe Fly
NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726
9M ago
NRBO
Is NRBO a Buy, Before Earnings?
PremiumPre-Earnings
Is NRBO a Buy, Before Earnings?
9M ago
NRBO
NeuroBo Partners for Monthly Dual-Action Diabetes Drug Development
PremiumCompany AnnouncementsNeuroBo Partners for Monthly Dual-Action Diabetes Drug Development
9M ago
8K
NRBO
NeuroBo Pharmaceuticals signs research agreement for obesity treatment
Premium
The Fly
NeuroBo Pharmaceuticals signs research agreement for obesity treatment
9M ago
NRBO
NeuroBo Pharmaceuticals Strikes Licensing Deal for NB-01
Premium
Company Announcements
NeuroBo Pharmaceuticals Strikes Licensing Deal for NB-01
9M ago
8K
NRBO
NeuroBo Pharmaceuticals announces license agreement with MThera Pharma
PremiumThe Fly
NeuroBo Pharmaceuticals announces license agreement with MThera Pharma
9M ago
NRBO
NeuroBo Pharmaceuticals files to sell 17.18M shares of common stock for holders
PremiumThe Fly
NeuroBo Pharmaceuticals files to sell 17.18M shares of common stock for holders
10M ago
NRBO
NeuroBo Pharmaceuticals Releases Corporate Presentation Update
PremiumCompany Announcements
NeuroBo Pharmaceuticals Releases Corporate Presentation Update
10M ago
8K
NRBO
NeuroBo Pharmaceuticals doses first patient in MAD Part 2 of DA-1726 trial
PremiumThe Fly
NeuroBo Pharmaceuticals doses first patient in MAD Part 2 of DA-1726 trial
11M ago
NRBO
NeuroBo Pharmaceuticals to sell 4.33M shares at $3.93 in private placement
PremiumThe FlyNeuroBo Pharmaceuticals to sell 4.33M shares at $3.93 in private placement
11M ago
NRBO
NeuroBo Pharmaceuticals’ DA-1726 demonstrates ‘superiority in weight loss’
Premium
The Fly
NeuroBo Pharmaceuticals’ DA-1726 demonstrates ‘superiority in weight loss’
11M ago
NRBO
NeuroBo Pharmaceuticals Enhances Equity Plan and Elects Directors
Premium
Company Announcements
NeuroBo Pharmaceuticals Enhances Equity Plan and Elects Directors
11M ago
8K
NRBO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >